November 25th 2025, 10:00pm
Stage 1 polycythemia vera is manageable with monitoring, phlebotomy, medication and lifestyle changes, allowing patients to live healthy, normal lives.
November 25th 2025, 9:00pm
Immunotherapies have represented a revolution in the landscape of cancer treatment — and may have a crucial partner in the form of personalized cancer vaccines.
November 25th 2025, 7:32pm
The FDA approved Imfinzi with chemotherapy for adults with resectable gastric or gastroesophageal junction adenocarcinoma.
November 25th 2025, 6:00pm
Surviving breast cancer changes the way you see your body. Every ache, every spot, every unfamiliar sensation becomes a quiet question: “Could it be coming back?”
November 25th 2025, 5:00pm
From diagnosis to treatment, here is what patients need to know about squamous cell carcinoma of the bladder.
November 25th 2025, 4:00pm
The FDA granted fast track designation to AVZO-103 for the treatment of patients with previously treated locally advanced or metastatic urothelial cancer.
November 25th 2025, 2:00pm
An expert explains how minimally invasive surgery helps remove smaller lung areas with quicker recovery and improves outcomes for patients with early-stage lung cancer.
November 24th 2025, 10:00pm
I share how the holidays feel different after loss and how grief, love and gratitude can coexist as I navigate this season with gentleness and care.
November 24th 2025, 9:00pm
Dr. Charles M. Rudin highlights T cell engagers, antibody-drug conjugates and emerging strategies showing early benefits for small cell lung cancer.
November 24th 2025, 8:00pm
The phase 2 SANRECO study has recently completed enrollment and will evaluate divesiran, a potential therapy for patients with polycythemia vera.
Understanding Stage 1 Polycythemia Vera: What Every Patient Should Know
How Vaccines Can Partner With Immunotherapy to Treat Lung Cancer
FDA Approves Imfinzi Plus Chemo in GC/GEJC
More Than a Cyst: The Fear Cancer Leaves Behind